Loading
  • Home
  • About
  • Technology
  • Pipeline
  • Careers
  • Investors & Media
  • Contact
  • Twitter
  • LinkedIn
  • Close Menu
  • Menu Menu

About Us

Replacing biologics and peptides with innovative, small molecule drugs.

Structure’s Mission

Biologics and peptides have revolutionized healthcare – offering life-changing, breakthrough medicines to patients in desperate need. These highly innovative large molecules have now set the stage for a new generation of equally transformative orally available small molecule medicines. The global patient need remains immense, and with enhanced pharmaceutical properties, such as improved oral bioavailability, stability, easier logistics and reduced cost, small molecule medicines could address a market worth more than $300 billion annually.

THIS IS EXACTLY WHAT OUR TEAM AT STRUCTURE IS DRIVEN TO ACCOMPLISH.

DRUG DISCOVERY EXPERTISE

Harnessing structure-based drug design, coupled with our advanced computational technologies and world-class expertise, we are committed to converting biologics and peptides into life-changing small molecule medicines for everyone around the world.

Our Team

Global solutions require global expertise. At Structure, we are led by an experienced group of drug hunters and industry leaders from around the world, including scientific experts who are renowned in the field of GPCR-targeted structure-based drug discovery. Our team includes pioneers in solving various G-protein coupled receptor (GPCR) protein structures, providing a strong foundation for tackling even the most difficult drug targets.

Raymond Stevens, Ph.D.

April 4, 2022
Chief Executive Officer
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Ray.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:39:512022-06-17 16:44:05Raymond Stevens, Ph.D.

Mark Bach, M.D., Ph.D.

April 4, 2022
Chief Medical Officer
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Mark.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:50:052022-06-17 16:44:39Mark Bach, M.D., Ph.D.

Melita Sun Jung

April 4, 2022
Chief Business Officer
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Melita.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:50:552022-06-17 16:44:58Melita Sun Jung

Xichen Lin, Ph.D.

April 4, 2022
Chief Scientific Officer
General Manager,
Structure Shanghai
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots_xiChen-1.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:51:172022-08-09 12:04:58Xichen Lin, Ph.D.

Yingli Ma, Ph.D.

April 4, 2022
Chief Technology Officer
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots_Yingli-1.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:51:532022-09-14 16:30:19Yingli Ma, Ph.D.

Jun Yoon

April 4, 2022
Chief Financial Officer
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots_Jun-1.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:51:342022-07-25 16:38:00Jun Yoon

Fang Zhang, Ph.D.

April 4, 2022
Executive Vice President
Head of Biology
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Fang.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:52:112022-06-22 16:16:43Fang Zhang, Ph.D.

Lani Ibarra

April 4, 2022
Senior Vice President
Clinical Development Operations
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Lani.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:52:362022-06-22 16:15:31Lani Ibarra

Xinglong Jiang, Ph.D.

April 4, 2022
Senior Vice President
Preclinical Development
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Xing.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:52:592022-06-22 16:14:17Xinglong Jiang, Ph.D.

Hui Lei, Ph.D.

April 4, 2022
Senior Vice President
Chemistry
https://structuretx.com/wp-content/uploads/ShouTi_Headshot_Hui_Lei_02.10.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:53:172022-06-22 16:13:12Hui Lei, Ph.D.

Marc Navre, Ph.D.

April 4, 2022
Senior Vice President
Head of Biology
Structure Basecamp Bio
https://structuretx.com/wp-content/uploads/Marc-Navre.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:53:552022-06-22 16:10:12Marc Navre, Ph.D.

Tony Peng

April 4, 2022
Senior Vice President
Legal
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-Tony-Peng-v3.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:54:132022-06-22 16:09:08Tony Peng

Karen S. Wright

April 4, 2022
Senior Vice President
Finance and Controller
https://structuretx.com/wp-content/uploads/Shou-Ti-Headshots-V2-Karen.png 600 600 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 09:54:322022-06-22 16:07:51Karen S. Wright

Board of Directors

Daniel G. Welch

April 4, 2022
Chairman
Former Chief Executive Officer,
InterMune
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 10:04:342023-02-02 14:41:32Daniel G. Welch

Eric Dobmeier

January 17, 2023
Chief Executive Officer,
Chinook Therapeutics
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 eallison /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg eallison2023-01-17 17:10:422023-01-17 17:12:21Eric Dobmeier

Ramy Farid, Ph.D.

April 4, 2022
Chief Executive Officer,
Schrödinger
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 10:04:572022-06-27 11:33:44Ramy Farid, Ph.D.

Raymond Stevens, Ph.D.

April 4, 2022
Chief Executive Officer,
Structure Therapeutics
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 10:05:372022-07-25 17:00:10Raymond Stevens, Ph.D.

Sharon Tetlow

April 4, 2022
Chair of the Audit Committee
Managing Partner,
Potrero Hill Advisors
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 Andrea Kushner /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg Andrea Kushner2022-04-04 10:05:552023-02-02 14:36:20Sharon Tetlow

Joanne Waldstreicher, M.D.

January 17, 2023
Chief Medical Officer,
Johnson & Johnson
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg 0 0 eallison /wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg eallison2023-01-17 16:59:432023-01-17 17:15:35Joanne Waldstreicher, M.D.
Privacy Policy | Terms of Use 2023 Structure Therapeutics
Scroll to top